Ensign Peak Advisors’s Vaxart VXRT Stock Holding History

Ensign Peak Advisors’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-39,240	Closed	-$137K	–	2354
2022 Q2	$137K	Hold	39,240	–	–	﹤0.01%	1900
2022 Q1	$198K	Hold	39,240	–	–	﹤0.01%	1881
2021 Q4	$246K	Buy	+39,240	New	+$268K	﹤0.01%	1879

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ensign Peak Advisors's VXRT Position: Q3 2022 in Review

Ensign Peak Advisors sold out of Vaxart (VXRT) in Q3 2022, closing a stake of 39,240 shares — an estimated $137K sold.

Ensign Peak Advisors first reported a position in VXRT in Q4 2021 and held it in 3 quarters. The position peaked at $246K in Q4 2021. 143 funds tracked by Wall St. Rank hold VXRT as of Q3 2022.

Ensign Peak Advisors reported no remaining Vaxart position as of Q3 2022 after selling out during the quarter.
Ensign Peak Advisors sold 39,240 Vaxart shares in Q3 2022, an estimated $137K.
Ensign Peak Advisors first reported a position in Vaxart in Q4 2021 and held it in 3 quarters.
Ensign Peak Advisors's Vaxart position peaked at $246K in Q4 2021.
143 funds tracked by Wall St. Rank held Vaxart as of Q3 2022.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.